05.26.14
West Pharmaceutical Services Inc. has received CE mark approval for its intradermal (ID) adapter, a device designed to help improve the consistency and reliability of intradermal injections.
The ID adapter makes intradermal injections easier and more consistent by guiding the angle and limiting the depth of needle insertion into the skin's intradermal layer. This injection aid technology, cleared by the U.S. Food and Drug Administration in February 2013, is designed for use with 1 mL disposable syringes.
The system complements West's portfolio of reconstitution, safety and transfer systems. West conducted two clinical studies that verified the performance of the ID adapter and confirmed a strong clinician preference for the device.
"We are delighted to offer our European customers a solution which can improve reliability and performance of intradermal injections and meet growing market demands in this area," said Zach Marks, marketing director of Pharmaceutical Delivery Systems at West.
The sterile, single-use injection-molded adapter snaps onto a 1 mL staked needle disposable allergy syringe with needles one-half-inch long (27, 28, 29 gauge). The system uses current drug/vaccine vials and commercially available syringes, minimizing disruptions to clinical practices.
Correctly administered injections can help conserve the supply of high-value vaccines and provide patients with a more reliable injection. West claims its ID adapter provides an alternative to the Mantoux method, the industry's standard for intradermal injections for more than a century; the current method requires extensive training and experience to perform correctly and consistently.
Based in Exton, Pa., West Pharmaceutical Services manufactures drug-delivery components and systems.
The ID adapter makes intradermal injections easier and more consistent by guiding the angle and limiting the depth of needle insertion into the skin's intradermal layer. This injection aid technology, cleared by the U.S. Food and Drug Administration in February 2013, is designed for use with 1 mL disposable syringes.
The system complements West's portfolio of reconstitution, safety and transfer systems. West conducted two clinical studies that verified the performance of the ID adapter and confirmed a strong clinician preference for the device.
"We are delighted to offer our European customers a solution which can improve reliability and performance of intradermal injections and meet growing market demands in this area," said Zach Marks, marketing director of Pharmaceutical Delivery Systems at West.
The sterile, single-use injection-molded adapter snaps onto a 1 mL staked needle disposable allergy syringe with needles one-half-inch long (27, 28, 29 gauge). The system uses current drug/vaccine vials and commercially available syringes, minimizing disruptions to clinical practices.
Correctly administered injections can help conserve the supply of high-value vaccines and provide patients with a more reliable injection. West claims its ID adapter provides an alternative to the Mantoux method, the industry's standard for intradermal injections for more than a century; the current method requires extensive training and experience to perform correctly and consistently.
Based in Exton, Pa., West Pharmaceutical Services manufactures drug-delivery components and systems.